PortfoliosLab logoPortfoliosLab logo
KOD vs. AVXL
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

KOD vs. AVXL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kodiak Sciences Inc. (KOD) and Anavex Life Sciences Corp. (AVXL). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

KOD vs. AVXL - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
KOD
Kodiak Sciences Inc.
36.34%181.01%227.30%-57.54%-91.55%-42.29%104.18%913.38%-30.12%
AVXL
Anavex Life Sciences Corp.
-13.76%-66.85%15.36%0.54%-46.60%221.11%108.49%66.03%-37.35%

Fundamentals

EPS

KOD:

-$4.11

AVXL:

-$0.46

Total Revenue (TTM)

KOD:

$0.00

AVXL:

$0.00

Gross Profit (TTM)

KOD:

-$26.49M

AVXL:

$0.00

EBITDA (TTM)

KOD:

-$190.85M

AVXL:

-$28.87M

Returns By Period

In the year-to-date period, KOD achieves a 36.34% return, which is significantly higher than AVXL's -13.76% return.


KOD

1D
13.25%
1M
42.24%
YTD
36.34%
6M
132.86%
1Y
1,259.00%
3Y*
83.20%
5Y*
-18.97%
10Y*

AVXL

1D
8.87%
1M
-30.70%
YTD
-13.76%
6M
-65.51%
1Y
-64.22%
3Y*
-28.98%
5Y*
-27.55%
10Y*
-4.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KOD vs. AVXL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KOD
KOD Risk / Return Rank: 9999
Overall Rank
KOD Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
KOD Sortino Ratio Rank: 9999
Sortino Ratio Rank
KOD Omega Ratio Rank: 9898
Omega Ratio Rank
KOD Calmar Ratio Rank: 100100
Calmar Ratio Rank
KOD Martin Ratio Rank: 100100
Martin Ratio Rank

AVXL
AVXL Risk / Return Rank: 1212
Overall Rank
AVXL Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
AVXL Sortino Ratio Rank: 1313
Sortino Ratio Rank
AVXL Omega Ratio Rank: 1111
Omega Ratio Rank
AVXL Calmar Ratio Rank: 1212
Calmar Ratio Rank
AVXL Martin Ratio Rank: 1212
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KOD vs. AVXL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kodiak Sciences Inc. (KOD) and Anavex Life Sciences Corp. (AVXL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


KODAVXLDifference

Sharpe ratio

Return per unit of total volatility

8.92

-0.72

+9.64

Sortino ratio

Return per unit of downside risk

5.47

-0.87

+6.34

Omega ratio

Gain probability vs. loss probability

1.66

0.87

+0.79

Calmar ratio

Return relative to maximum drawdown

37.34

-0.81

+38.16

Martin ratio

Return relative to average drawdown

73.29

-1.40

+74.70

KOD vs. AVXL - Sharpe Ratio Comparison

The current KOD Sharpe Ratio is 8.92, which is higher than the AVXL Sharpe Ratio of -0.72. The chart below compares the historical Sharpe Ratios of KOD and AVXL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


KODAVXLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

8.92

-0.72

+9.64

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

-0.33

+0.16

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.06

Sharpe Ratio (All Time)

Calculated using the full available price history

0.19

-0.05

+0.24

Correlation

The correlation between KOD and AVXL is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

KOD vs. AVXL - Dividend Comparison

Neither KOD nor AVXL has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

KOD vs. AVXL - Drawdown Comparison

The maximum KOD drawdown since its inception was -99.15%, roughly equal to the maximum AVXL drawdown of -97.06%. Use the drawdown chart below to compare losses from any high point for KOD and AVXL.


Loading graphics...

Drawdown Indicators


KODAVXLDifference

Max Drawdown

Largest peak-to-trough decline

-99.15%

-97.06%

-2.09%

Max Drawdown (1Y)

Largest decline over 1 year

-32.40%

-79.57%

+47.17%

Max Drawdown (5Y)

Largest decline over 5 years

-98.91%

-90.51%

-8.40%

Max Drawdown (10Y)

Largest decline over 10 years

-90.51%

Current Drawdown

Current decline from peak

-76.82%

-89.36%

+12.54%

Average Drawdown

Average peak-to-trough decline

-63.68%

-64.88%

+1.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.51%

46.14%

-29.63%

Volatility

KOD vs. AVXL - Volatility Comparison

Kodiak Sciences Inc. (KOD) has a higher volatility of 61.06% compared to Anavex Life Sciences Corp. (AVXL) at 47.17%. This indicates that KOD's price experiences larger fluctuations and is considered to be riskier than AVXL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


KODAVXLDifference

Volatility (1M)

Calculated over the trailing 1-month period

61.06%

47.17%

+13.89%

Volatility (6M)

Calculated over the trailing 6-month period

87.44%

82.27%

+5.17%

Volatility (1Y)

Calculated over the trailing 1-year period

142.85%

88.81%

+54.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

108.72%

83.16%

+25.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

104.86%

85.60%

+19.26%

Financials

KOD vs. AVXL - Financials Comparison

This section allows you to compare key financial metrics between Kodiak Sciences Inc. and Anavex Life Sciences Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober00
(KOD) Total Revenue
(AVXL) Total Revenue
Values in USD except per share items